Healthcare

AVITA Medical, Inc. (ASX:AVH)

Industry Group : Pharmaceuticals, Biotechnology & Life Sciences | Industry Group Name : Biotechnology

Market Price : AUD 3.81-0.08 (2.057%)

(as on 2021-12-01 20:55:24 AEDT)

Market Cap : AUD 474.823 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
3.89 3.88 3.81 3.810L 3.920 H 3.810L 7.400 H
Last Trade 3.81
Change% -2.0566
52 W H/L 7.400/3.810
EBITDA -21.568 M
NPAT After Abnormal Items -35.359 M
Equity 153.837 M
ROE% -22.98%
Total Liabilities 13.097 M
Total Revenue 41.639 M
Cash and Cash Equivalents 147.308 M

Stock Information

Share price 3.81
Market Cap 474.823 M
Price/Gross Cash Flow -5.48
Dividend Yield Excluding Special 0.00%
Ending Shares 24.896 M
52-Week Range 7.400-3.810
P/E ratio 0.000
Sector P/E --
EPS -155.63
EV/EBITDA --
Net Profit Margin (%) -90.94%
Gross Cash Flows Per Share -1.05
Net Gearing -94.56%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 6.15
Sales Per Share 1.71
Book Value Per Share 6.18

Announcements

Heading Date/Time
AVITA Medical to Present at Upcoming Investor Conferences  17/11/2021 8:24AM
Template CDI Voting Instruction Form  10/11/2021 9:29AM
Definitive Proxy Statement  10/11/2021 8:29AM
Financial Report for Fiscal First Quarter 2021 Form 10Q  09/11/2021 10:33AM
AVITA Medical Corporate Presentation November 2021  09/11/2021 10:05AM
AVITA Medical Reports Fiscal Q1 2022 Financial Results  09/11/2021 8:39AM
Substantial Holder Notice  05/11/2021 1:34PM
Statement of CDIs on issue - AVH  05/11/2021 1:05PM
AVITA Medical Announces Expanded Medicare Reimbursement  04/11/2021 8:24AM
Regional Burn Conferences 12 RECELL Presentations  29/10/2021 9:54AM
Notification of cessation of securities - AVH  27/10/2021 4:18PM
AVITA Medical to Announce 1st Quarter 2022 Financial Results  26/10/2021 9:57AM
Notification regarding unquoted securities - AVH  14/10/2021 3:17PM
Statement of CDIs on issue - AVH  07/10/2021 3:23PM
AVITA Medical Investor Briefing Correction:1 October at 9am  27/09/2021 9:48AM
AVITA Medical Investor Briefing to be held 9 October at 9am  27/09/2021 8:40AM
Change of Director's Interest Notice - Suzanne Crowe  23/09/2021 8:27AM
Notification of cessation of securities - AVH  23/09/2021 8:25AM
AVITA Medical to Present at Cantor Healthcare Conference  14/09/2021 8:21AM
Notice under section 708A(5)(e) of the Corporations Act  09/09/2021 4:56PM
Change of Director's Interest Notice - Michael Perry  09/09/2021 4:35PM
Notification regarding unquoted securities - AVH  09/09/2021 4:28PM
Statement of CDIs on issue - AVH  07/09/2021 3:15PM
Notification of cessation of securities - AVH  03/09/2021 1:58PM
Notification regarding unquoted securities - AVH  01/09/2021 4:12PM
AVITA Medical To Participate at Lake Street BIG5 Conference  01/09/2021 8:20AM
Appendix 4G and Corporate Governance Statement  27/08/2021 8:32AM
Avita Medical Corporate Presentation  27/08/2021 8:27AM
Fourth Quarter and Fiscal Year 2021 Financial Results  27/08/2021 8:22AM

Similar Companies

Related Articles

Load More

About Company

AVITA Therapeutics Inc (ASX: AVH) is a group addressing both medical and aesthetic indications. Primarily, Avita Medical Ltd is a medical technology company which develops, manufactures and distributes innovative products for the regenerative medicine and respiratory markets. The company has a clinical pipeline of products with great value. Further, its platform is capable of delivering more regenerative medicine products in the future.

Corporate Information

company address C/- Corporate Creations Network, Inc., S, NEW CASTLE COUNTY, DEL, UNITED STATES OF AMERICA, 19810

company phone+ 1 661 367-9178

company websitehttp://www.avitamedical.com

Dividends

Year-end Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 0.00%
30/06/2017 -- 0.000 0.00%
30/06/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 0.00%
30/06/2013 -- 0.000 0.00%
30/06/2012 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-26 2022
Report (Prelim) 2022-08-26 2022
Report (Interim) 2022-02-16 2022

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 38.883 M 20.782 M 7.705 M 1.652 M 1.181 M
Other Revenue 2.756 M 6.72 M 8.716 M 9.654 M 6.828 M
Total Revenue 41.639 M 27.503 M 16.421 M 11.306 M 8.009 M
Interest Income 0 0 0 65,656 123,709
Interest Expenses -29,263 -48,083 -37,769 -26,586 -12,754
Expenses -75.967 M -88.013 M -51.346 M -29.106 M -20.539 M
EBITDA -34.328 M -60.51 M -34.924 M -17.8 M -12.531 M
Depreciation and Amortization -951,050 -677,546 -378,002 -143,546 -139,703
Depreciation -806,065 -504,152 -378,002 -143,546 -139,703
Amortisation -144,985 -173,393 0 0 0
EBIT -35.279 M -61.188 M -35.302 M -17.944 M -12.67 M
Pre Tax Profit -35.309 M -61.236 M -35.34 M -17.905 M -12.559 M
Tax Expense -50,545 -5,828 179,863 1.42 M 1.048 M
Net Profit After Tax -35.359 M -61.241 M -35.16 M -16.484 M -11.511 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 0 0 0 0
Reported Net Profit After Abnormal Items -35.359 M -61.241 M -35.16 M -16.484 M -11.511 M
Ending Shares 24.896 M 107.34 M 93.565 M 63.869 M 708.992 M
Weighted Average Shares 22.674 M 101.455 M 63.333 M 46.716 M 750.454 M
EPS After Abnormal Items (cents) -155.94 -60.36 -55.52 -35.29 -1.53
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 161.386 M 114.217 M 34.579 M 22.274 M 7.281 M
Total Non Current Assets 5.548 M 5.938 M 2.159 M 742,583 387,380
Total Assets 166.934 M 120.154 M 36.738 M 23.017 M 7.668 M
Total Current Liabilities 9.83 M 11.233 M 6.284 M 3.883 M 2.546 M
Total Non Current Liabilities 3.267 M 3.427 M 664,731 134,338 0
Total Liabilities 13.097 M 14.66 M 6.949 M 4.017 M 2.546 M
Net Assets 153.837 M 105.495 M 29.789 M 19 M 5.122 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash -34.452 M -33.144 M -27.486 M -16.372 M -8.558 M
Net Invested Cash -1.562 M -1.234 M -1.795 M -498,749 195,245
Net Financing Cash Flows 85.194 M 112.279 M 41.297 M 27.935 M 8.238 M
Beginning Cash 98.218 M 29.687 M 14.826 M 3.79 M 4.172 M
End Cash Position 147.575 M 107.591 M 28.983 M 14.826 M 3.79 M
Exchange Rate Adjustments 176,908 4,371 2.141 M -29,106 -257,238
Other Cash Adjustments 0 0 0 0 0
Ending Cash 147.575 M 107.591 M 28.983 M 14.826 M 3.79 M

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK